STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 9th, 2018 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 9th, 2018 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is made and entered into as of September 13, 2018, by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and John K. Scott Jr. (the “Investor”).
AGREEMENTShareholder Agreement • November 9th, 2018 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledNovember 9th, 2018 Company Industry JurisdictionThis Agreement is dated effective as of August 14, 2018, by and among Navidea Biopharmaceuticals, Inc. (“Navidea”), Macrophage Therapeutics, Inc. (“MT”) and Michael M. Goldberg, M.D. (“Goldberg”). The transactions contemplated by this Agreement is collectively referred to herein as the “Transaction.”